Pandemic Darlings The pandemic economy, in original documents
Home Source documents Co-Diagnostics, Inc. Form 4 — Reagents, LLC (Sept. 19, 2017)Search ⌕

Co-Diagnostics, Inc. Form 4 — Reagents, LLC (Sept. 19, 2017)

Summary

A Form 4 filed with the Securities and Exchange Commission by Reagents, LLC, a former 10% owner of Co-Diagnostics, Inc. (CODX), with an earliest transaction date of 09/19/2017. It reports the transfer of 25,000 shares of common stock on 04/01/2020, leaving 1,746,796 shares owned directly. The explanation states that the shares had been pledged under a stock pledge agreement to secure a promissory note and were transferred as full and final satisfaction of the $192,505 outstanding principal, after the reporting person ceased to be a 10% owner. The form is signed /s/ Seth Egan and dated 01/22/2021.

Summary drafted by a model from the document's text below and checked by script against that text before publication. It is a navigation aid, not a reading of what the document proves. Where AI is used

Cite this document

“Co-Diagnostics, Inc. Form 4 — Reagents, LLC (Sept. 19, 2017).” Original at www.sec.gov. Archived at Pandemic Darlings, https://pandemicdarlings.com/source-documents/sec-codx-4-filed2021-01-22-0001493152-21-001603-90e5ec9878/, SHA-256 0add8985c0bfa490cfcff57a9f927e30f84aaf8a0cdcb93460ac6bd496dd6135.

Full text

SEC Form 4

FORM 4 | UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 | OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5 | OMB APPROVAL | OMB Number: 3235-0287 Estimated average burden hours per response: 0.5 | OMB Number: | 3235-0287 | Estimated average burden | hours per response: | 0.5
X | X | Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person * Reagents, LLC (Last) (First) (Middle) 8160 S. HIGHLAND DR (Street) SANDY UT 84093 (City) (State) (Zip) | Reagents, LLC | (Last) | (First) | (Middle) | 8160 S. HIGHLAND DR | SANDY | UT | 84093 | (City) | (State) | (Zip) | 2. Issuer Name and Ticker or Trading Symbol Co-Diagnostics, Inc. [ CODX ] | 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner Officer (give title below) X Other (specify below) Former 10% Owner | Director | 10% Owner | Officer (give title below) | X | Other (specify below) | Former 10% Owner
3. Date of Earliest Transaction
 (Month/Day/Year) 09/19/2017
4. If Amendment, Date of Original Filed
 (Month/Day/Year) | 6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person | X | Form filed by One Reporting Person | Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr.
 3) | 2. Transaction Date
 (Month/Day/Year) | 2A. Deemed Execution Date, if any
 (Month/Day/Year) | 3. Transaction Code (Instr.
 8) | 4. Securities Acquired (A) or Disposed Of (D) (Instr.
 3, 4 and 5) | 5.
 Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr.
 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr.
 4) | 7. Nature of Indirect Beneficial Ownership (Instr.
 4)
Code | V | Amount | (A) or (D) | Price
Common Stock | 04/01/2020 | J | 25,000 | D | $ 192,505 (1) | 1,746,796 | D
Common Stock | 09/19/2017 | J | 181,817 | D | $ 0 (2) | 1,771,796 | D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr.
 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date
 (Month/Day/Year) | 3A. Deemed Execution Date, if any
 (Month/Day/Year) | 4. Transaction Code (Instr.
 8) | 5.
 Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr.
 3, 4 and 5) | 6. Date Exercisable and Expiration Date
 (Month/Day/Year) | 7. Title and Amount of Securities Underlying Derivative Security (Instr.
 3 and 4) | 8. Price of Derivative Security (Instr.
 5) | 9.
 Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr.
 4) | 10. Ownership Form: Direct (D) or Indirect (I) (Instr.
 4) | 11. Nature of Indirect Beneficial Ownership (Instr.
 4)
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares
Explanation of Responses:
1. Pursuant to a stock pledge agreement between the Reporting Person and an unaffiliated third party (the "Pledgee"), dated on or about July, 2018, as amended (the "Pledge Agreement"), the Reporting Person secured a promissory note by a pledge of 25,000 shares of common stock of the Issuer (the "Shares"). On January 28, 2020, the Reporting Person ceased to be a 10% owner of shares of common stock of the Issuer. Thereafter, in April of 2020, the Pledgee exercised its right under the Pledge Agreement and transferred the entirety of the Shares as full and final satisfaction of the $192,505 outstanding principal amount due under the promissory note. Accordingly, although this Form 4 is being filed to report such transfer from the Reporting Person, the transfer occurred after the Reporting Person ceased to be a 10% owner of shares of common stock of the Issuer.
2. The total number of shares reported contains a de minimis correction to the balance on the Reporting Person's Form 3 previously filed on September 19, 2017.
/s/ Seth Egan | 01/22/2021
** Signature of Reporting Person | Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction
 4

 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

File and source

File
SEC_CODX_4_filed2021-01-22_0001493152-21-001603.xml
Size
16,564 bytes
SHA-256
0add8985c0bfa490cfcff57a9f927e30f84aaf8a0cdcb93460ac6bd496dd6135
Our copy
SEC_CODX_4_filed2021-01-22_0001493152-21-001603.xml
Original
www.sec.gov
Back to top